Introduction:The purpose of this review is to examine the clinical relevance of the statistically significant effects of monoamine oxidase-B inhibitors (MAO-B) inhibitors in Parkinson's disease (PD).
Methods and Results:We applied the Minimal Clinically Important Difference (MCID) as a way to evaluate results as clinically significant and make a reference to the studies that calculated MCID for PD.
AbstractClinical relevance of MAO-B inhibitors 2 ARC Publishing
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.